TABLE 1

Clinical presentation of 17 patients with SFTPC mutations

nFemale/male nGestational ageAge at onsetNeonatal symptoms nPost neonatal symptoms nMechanical ventilation n (age)Failure to thrive nOther diagnosis n
All patients
1710/739 (36–43) weeks2 (0–132) months9 yes, of whom:  3 RDS;  4 tachy/dyspnoea;  1 cyanosis;  1 staphylodermia17 yes, of whom:  17 tachypnoea, oxygen demand;  3 spontaneous pneumothorax;  2 persistent pulmonary hypertension;  2 cyanosis;  5 abnormal skeletal thorax;  17 recurrent infections of which:  5 RSV pneumonia;  2 Chlamydophilia pneumoniae pneumonia;  3 Pseudomonas aeruginosa pneumonia;  1 influenza pneumonia;  1 chronic disseminated cytomegalovirus infection;  1 methicillin-resistant Staphylococcus aureus pneumonia11 (1 (0–24) month)15 yes, of whom:  9 percutaneous endoscopic gastrostomy;  4 gastro-oesophageal reflux disease;  1 cow milk allergy10 yes, of whom:  5 cardiac anomalies; 2 mental retardation; 8 other diagnosis#
Non-BRICHOS domain mutations
106/439 (36–40) weeks0.3 (0–11) years3 yes, 1 unknown10 yes7 yes (4.8 (0–24) months)9 yes4 yes, 1 unknown
BRICHOS domain mutations
74/339 (36–43) weeks0 (0–3) months6 yes7 yes4 yes (0 (0–19) months)5 yes5 yes
p-value0.06nsnsnsns
  • Data are presented as median (range), unless otherwise stated. RDS: respiratory distress syndrome; RSV: respiratory syncytial virus; PEG: percutaneous endoscopic gastrostomy; ns: not significant. #: see table s1 in the online supplementary material : Fisher's exact test comparing frequencies between BRICHOS/non-BRICHOS mutations.